KVUE (kenvue.com) Bozor qiymatining balans qiymatiga nisbati

Kenvue Inc (KVUE) kompaniyasining rasmiy ramzlari

Kundalik sog'liqni saqlash mahsulotlariga bo'lgan barqaror talab Kenvue Inc. (KVUE) kompaniyasining chidamliligini ta'minlaydi, buni hozirda 3.54 darajasida bo'lgan bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book ratio) tasdiqlaydi. Ushbu tendentsiya optimallashtirilgan logistikaga ega bo'lgan zavodlarning global tarmog'i va yuqori toifali tadqiqotchilar jamoasi tomonidan qo'llab-quvvatlanmoqda. Kuchli brend imidji xodimlar uchun ishonchlilikni kafolatlaydi va investorlarga bozorning tez-tez uchraydigan tebranishlaridan himoyani taqdim etadi.

KVUE Kenvue Health: Balans qiymatiga nisbatan bozor qiymati 21.02.2024 - 28.10.2026 oraligʻida

Kenvue Inc (KVUE) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Kenvue Inc.|KVUE - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Kenvue Corp|KVUE - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Kenvue|KVUE - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati kenvue.com|KVUE - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Kenvue Inc.|KVUE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Kenvue Corp|KVUE - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Kenvue Corp
Kompaniyaning dastlabki tahlili:Kenvue Inc. - KVUE
Kenvue Corp original mahsuloti

Ushbu koeffitsient sof aktivlardan yuqori bo'lgan bozor qiymati premiumini aks ettiradi va investorlarga kompaniya aktivlarining haqiqiy qiymatini birja kutimlari bilan nisbatan baholash imkonini beradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini tahlil qilish spekulyativ shovqinlarni filtrlashga yordam beradi, bu esa Kenvue Inc. (KVUE) uchun juda muhimdir, chunki uning kapitalizatsiyasi arzon generik dori vositalarining shiddatli raqobati sharoitida brend kuchiga asoslangan.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati HLN|VRNA (veronapharma.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Jyong Biotech MENS|Sof aktivlarga nisbatan bozor kapitallashuvi Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Perrigo Corp (PRGO)|Bozor kapitallashuvining balans qiymatiga nisbati ALVO (Alvotech)|liquidia.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Galapagos (GLPG)|ANIP: Balans qiymatiga nisbatan bozor qiymati|MNKD (MannKind Corp.) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati Cumberland Pharmaceuticals Inc CPIX|QNTM (Quantum BioPharma Limited) - Bozor kapitallashuvining balans qiymatiga nisbati|FGEN: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals|Kapitallashuvning balans qiymatiga nisbati Rani Therapeutics Holdings, Inc.|Kapitallashuvning sof aktivlarga nisbati Synergy CHC Corp.|Bozor qiymatining balans qiymatiga nisbati Rallybio Corp. (RLYB)|Kapitallashuvning sof aktivlarga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix Corporation (PULM)|PTHL: Bozor kapitallashuvining balans qiymatiga nisbati|APM - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Lyra Therapeutics (LYRA)|IBO - Balans qiymatiga nisbatan bozor qiymati|tnfpharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|YCBD (cbdMD) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati PainReform Ltd. (PRFX)|Kapitallashuvning balans qiymatiga nisbati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati OptiNose Inc OPTN|Kapitallashuvning sof aktivlarga nisbati PIRS|Procaps Group Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|Petros Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|qlsyy.net (QLI) - Bozor kapitallashuvining balans qiymatiga nisbati|ACELYRIN (SLRN) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati TFF Pharmaceuticals Inc.